Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationStem CellsTissue DonorsGraft SurvivalLeukemiaBusulfanLiver TransplantationHistocompatibility TestingHistocompatibilityTreatment OutcomeHematopoiesisAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationRetrospective StudiesCombined Modality TherapyImmunosuppressive AgentsRemission InductionCyclophosphamideKidney TransplantationLeukemia, Myeloid, AcuteGraft vs Leukemia EffectHematopoietic Stem Cell MobilizationTransplantation, IsogeneicAntigens, CD34Hepatic Veno-Occlusive DiseaseMyeloablative AgonistsTime FactorsBone and BonesMice, Inbred C57BLChimerismHematologic DiseasesCell DifferentiationHLA AntigensTransplantation ImmunologyMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisMultiple MyelomaSevere Combined ImmunodeficiencyBone Marrow PurgingSurvival RateGraft vs Tumor EffectGraft RejectionLymphocyte TransfusionColony-Forming Units AssayCell TransplantationDisease-Free SurvivalLymphocyte DepletionFlow CytometryMesenchymal Stem Cell TransplantationMelphalanAcute DiseaseLymphoma, Non-HodgkinT-LymphocytesImmunosuppressionCell LineageLeukemia, MyeloidBone Marrow DiseasesHeart TransplantationGranulocyte Colony-Stimulating FactorAntineoplastic Combined Chemotherapy ProtocolsCytomegalovirus InfectionsSiblingsFollow-Up StudiesRadiation ChimeraVidarabineUnrelated DonorsAntilymphocyte SerumLung TransplantationCells, CulturedOrgan TransplantationSalvage TherapyFetal BloodStem Cell NicheCyclosporineCell SeparationCytarabinePrognosisOpportunistic InfectionsEmbryonic Stem CellsAdult Stem CellsImmunocompromised HostLymphomaLymphoproliferative DisordersTransplantation